# PROstate Cancer Imaging, Treatment and Toxicity (PROCITT)

> **NCT01418040** · — · COMPLETED · sponsor: **Calvary Mater Newcastle, Australia** · enrollment: 28 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01418040
- **Lead sponsor:** Calvary Mater Newcastle, Australia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-28
- **Primary completion:** 2017-07-20
- **Final completion:** 2017-07-20
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01418040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01418040, "PROstate Cancer Imaging, Treatment and Toxicity (PROCITT)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01418040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*